Login / Signup

An open label pilot study of the safety and tolerability of perampanel in amyotrophic lateral sclerosis.

Mostafa HotaitHelen H IsmailGeorges E SaabJohnny S Salameh
Published in: Muscle & nerve (2021)
The use of perampanel in this study of ALS was limited by its poor tolerability.
Keyphrases
  • open label
  • double blind
  • clinical trial
  • placebo controlled
  • amyotrophic lateral sclerosis
  • study protocol